Walleye Capital
MEDP icon

Walleye Capital’s Medpace MEDP Stock Holding History

Walleye Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530K Buy
+1,000
New +$462K ﹤0.01% 2675
2025
Q3 		– Sell
-600
Closed -$188K – 4872
2025
Q2 		$188K Buy
+600
New +$180K ﹤0.01% 3408
2024
Q3 		– Sell
-10,900
Closed -$4.49M – 5650
2024
Q2 		$4.49M Buy
10,900
+7,700
+241% +$3.05M 0.01% 1366
2024
Q1 		$1.29M Buy
3,200
+400
+14% +$141K ﹤0.01% 2340
2023
Q4 		$858K Sell
2,800
-1,700
-38% -$459K ﹤0.01% 2485
2023
Q3 		$1.09M Buy
+4,500
New +$1.15M ﹤0.01% 2182
2023
Q2 		– Sell
-100
Closed -$18.8K – 4654
2023
Q1 		$18.8K Sell
100
-2,000
-95% -$414K ﹤0.01% 3413
2022
Q4 		$446K Buy
+2,100
New +$420K 0.01% 1528

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Walleye Capital's MEDP Position: Q2 2026 in Review

Walleye Capital reduced its Medpace (MEDP) stake by 94% in Q2 2026, selling an estimated $2.6M and leaving 351 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #3556.

Walleye Capital first reported a position in MEDP in Q3 2021 and has held it in 9 quarters since. The position peaked at $5.14M in Q4 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Walleye Capital held 351 shares of Medpace worth $186K as of Q2 2026.
  • Walleye Capital sold 5,644 Medpace shares in Q2 2026, an estimated $2.6M.
  • Medpace made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3556 holding.
  • Walleye Capital first reported a position in Medpace in Q3 2021 and has held it in 9 quarters since.
  • Walleye Capital's Medpace position peaked at $5.14M in Q4 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.